Imago Biosciences Financials
Based on the key indicators related to Imago Biosciences' liquidity, profitability, solvency, and operating efficiency, Imago Biosciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in May.
With this module, you can analyze Imago financials for your investing period. You should be able to track the changes in Imago Biosciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Imago |
Understanding current and past Imago Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Imago Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Imago Biosciences' assets may result in an increase in income on the income statement.
The data published in Imago Biosciences' official financial statements usually reflect Imago Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Imago Biosciences. For example, before you start analyzing numbers published by Imago accountants, it's critical to develop an understanding of what Imago Biosciences' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Imago Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Imago Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Imago Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Imago Biosciences. Please utilize our Beneish M Score to check the likelihood of Imago Biosciences' management manipulating its earnings.
Imago Biosciences Stock Summary
Imago Biosciences competes with Joint Corp, Duckhorn Portfolio, 908 Devices, National Beverage, and Coca Cola. Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1, an enzyme that used in the production of blood cells in the bone marrow. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Imago Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US45250K1079 |
| Business Address | 329 Oyster Point |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | www.imagobio.com |
| Phone | 415 529 5055 |
| Currency | USD - US Dollar |
You should never invest in Imago Biosciences without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Imago Stock, because this is throwing your money away. Analyzing the key information contained in Imago Biosciences' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Imago Biosciences Key Financial Ratios
Generally speaking, Imago Biosciences' financial ratios allow both analysts and investors to convert raw data from Imago Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Imago Biosciences over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Imago Biosciences reports annually and quarterly.Imago Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Imago Biosciences's current stock value. Our valuation model uses many indicators to compare Imago Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imago Biosciences competition to find correlations between indicators driving Imago Biosciences's intrinsic value. More Info.Imago Biosciences is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Imago Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Imago Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imago Biosciences' earnings, one of the primary drivers of an investment's value.Imago Biosciences Market Pulse
| Quote | 0.0 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 0.0 |
| Low | 0.0 |
| High | 0.0 |
| Volume | 1 |
| Exchange | NASDAQ |
About Imago Biosciences Financials
What exactly are Imago Biosciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Imago Biosciences' income statement, its balance sheet, and the statement of cash flows. Potential Imago Biosciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Imago Biosciences investors may use each financial statement separately, they are all related. The changes in Imago Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Imago Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Imago Biosciences Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Imago Biosciences is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Imago has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Imago Biosciences' financials are consistent with your investment objective using the following steps:- Review Imago Biosciences' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Imago Biosciences' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Imago Biosciences' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Imago Biosciences' stock is overvalued or undervalued.
Imago Biosciences April 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Imago Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Imago Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Imago Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Imago Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Imago Biosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.81 | |||
| Information Ratio | 0.1284 | |||
| Maximum Drawdown | 104.82 | |||
| Value At Risk | (2.31) | |||
| Potential Upside | 3.44 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Imago Biosciences information on this page should be used as a complementary analysis to other Imago Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Imago Stock
If you are still planning to invest in Imago Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Imago Biosciences' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |